Showing results (11-20 of 302) with videos related to

Sort By:
Pageof 31
Cancer Discovery|April 3, 2020
Not So FASt: Tumor Cells Resisting Death Drive CAR T-cell DysfunctionMichael R Green, Sattva S Neelapu
Cancers|July 2, 2021
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology ModelAnna Mueller-Schoell, Nahum Puebla-Osorio, Robin Michelet, et al.
Seminars in Oncology|February 19, 2004
Adoptive immunotherapy with antigen-specific T cells in myeloma: a model of tumor-specific donor lymphocyte infusionLarry W Kwak, Sattva S Neelapu, Michael R Bishop
Yonsei Medical Journal|February 28, 2007
Therapeutic vaccine for lymphomaSeung-Tae Lee, Sattva S Neelapu, Larry W Kwak
Current Opinion in Oncology|August 7, 2015
Targeting the programmed death-1/programmed death-ligand 1 axis in lymphomaChan Yoon Cheah, Nathan H Fowler, Sattva S Neelapu
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 2, 2021
Human herpesvirus 6 myelitis after chimeric antigen receptor T-cell therapyGuy Handley, Fareed Khawaja, Divya S Kondapi, et al.
Nature Reviews. Immunology|May 18, 2021
Cytokine release syndrome and associated neurotoxicity in cancer immunotherapyEmma C Morris, Sattva S Neelapu, Theodoros Giavridis, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2013
Combination of Pim kinase inhibitor SGI-1776 and bendamustine in B-cell lymphomaQingshan Yang, Lisa S Chen, Sattva S Neelapu, et al.
Pageof 31